Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
Go back to Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study| (NASDAQ: CMND) | Delayed: 1.03 -0.13 (11.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.15 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $ | |||
| Volume | 3,087,753 | |||||
